tirzepatide approved for obesity enhances weight loss with sustained treatment but discontinuation leads to weight regain Tirzepatide (AKA Mounjaro and Zepbound)

One of its benefits over other antidiabetic drugs is that it has a long length of activity, so a once seven days infusion is adequate

And it works

Obesity and growth during childhood and puberty

Meta-regression analysis identified mesenchymal stem cell therapy as the most effective intervention for pain reduction (with a statistically significant effect size), while PRP and peptide-based therapies showed moderate improvements across musculoskeletal conditions

Theyre both central nervous system (CNS) stimulant drugs that work by increasing levels of certain neurotransmitters in the brainbut thats where the similarities end